about
Subhealth: definition, criteria for diagnosis and potential prevalence in the central region of ChinaMetformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trialDrugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisOmega-3 polyunsaturated fatty acids for non-alcoholic fatty liver diseaseProbiotics for non-alcoholic fatty liver disease and/or steatohepatitisAntioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitisBile acids for non-alcoholic fatty liver disease and/or steatohepatitisDrugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisNonalcoholic fatty liver diseaseChronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetesMetabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential linkFibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersNonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementMethionine deficiency and hepatic injury in a dietary steatohepatitis modelEndothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in miceTreatment of non-alcoholic fatty liver diseaseRedox mechanisms in hepatic chronic wound healing and fibrogenesisCytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation studyClinical and histological features of nonalcoholic steatohepatitis in Iranian patientsMeasurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis.Micronutrient Antioxidants and Nonalcoholic Fatty Liver DiseaseMetabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseasesA Guide to Non-Alcoholic Fatty Liver Disease in Childhood and AdolescenceNAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver DiseaseChemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsSphingolipids in High Fat Diet and Obesity-Related DiseasesMicroRNAs in Nonalcoholic Fatty Liver DiseaseAnimal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and InflameThe Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver DiseaseContribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinomaNonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment StrategyAdvances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinomaHepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C TherapyAssociation of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis'Micro-managers' of hepatic lipid metabolism and NAFLDRoles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver DiseaseOmega-3 fatty acids for the treatment of non-alcoholic fatty liver diseaseNonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome
P2860
Q21257267-EE7FFFE9-5BF6-4E30-A8BB-4B8C39707653Q22242637-8C66D667-D5BB-455D-81A8-160B5105098FQ24197984-27B7DDBC-14FE-4C6D-B69A-F9ED9B6FD60DQ24202688-3E781CBE-9B23-4596-8712-FCAA97A2C6D0Q24243033-74B01BE7-B767-4658-9662-92BD7B2AEC14Q24243125-BFB16354-AAD6-4896-94CE-D2AD6EBDEE30Q24243149-4FC7D34D-6115-443C-9F38-45C92B19D3A1Q24246447-1F606850-FA69-47D0-A4C6-357C33300D4AQ24555779-FBC7C7D8-A177-47AE-84E4-EE002ACC30F4Q24618308-0312CBB1-B859-4298-84E7-61AF99E18374Q24631619-7E7838C8-169D-42E8-A0FE-41BBB3946B58Q24644869-3A25E32C-55D9-402E-B213-B60B26F08489Q24649618-761726C3-7FB1-40F7-A70A-5CB32F9930FCQ24650636-FAC6C87F-2BD5-479B-8B8C-61AEF01114E1Q24652041-B867CEDD-6F5E-42F6-8597-AE814E1E7532Q24655572-14D13F32-8EF9-46E8-B8D4-E912A31287CFQ24656684-56E50147-219D-4985-A202-0D7B1F17E9F8Q24657221-DF790DF3-EDB2-46D6-B10E-ABA9603ED409Q24792885-5A7E1971-F35F-49F0-9F99-F18E195A075EQ24815160-069288C3-3ACC-427F-A8A2-C7757D8D7F25Q26738646-CC0D55F9-12E4-476C-82E3-29E0A230E78FQ26741550-310314AA-AF94-4FCA-9924-321F05CD945CQ26744488-68E5B41F-6671-4326-8C9C-1AD011865BDEQ26750955-7CCE9BB6-B00B-48DB-8391-1960CC4FFB85Q26752762-6EE5C3F3-2AF7-4A0A-84F2-843171F9EC6CQ26772302-259DF4CE-7477-4E0B-A73E-4022FF35DACBQ26773230-C308E98D-5E7B-4772-B1A0-96C820DD5836Q26774294-51D61543-1350-4527-B97F-7C294DA18133Q26775571-C4480F67-7DF6-4A1D-964B-22A20ABF1687Q26780509-D8C6A99A-0739-4750-92AA-964B625DBEC9Q26781477-A83EF505-AD89-4CB3-A0DF-B5E65522FA01Q26781753-1B621D61-FB77-4FC5-96E2-F7EB1B87413CQ26795529-7509CB0F-4142-482B-8857-54383F9F5DB8Q26795750-C106169A-C729-4C95-90C2-94652003D638Q26798155-B20E909B-5871-4DFF-A6D8-8E78D3577988Q26801228-B36C2F6E-6254-4E98-B4B5-ACDBFECF32C8Q26801371-B06BF511-FCB5-4546-857E-173E6193C2F4Q26825517-9A89DF20-A582-4B73-905A-10EF34E5CCBCQ26827169-B096AF35-DAC4-4E9B-9048-36ECAE3CD22CQ26828765-E563D581-D15E-45C3-BDE8-A6DCBEDF51D3
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nonalcoholic fatty liver disease
@ast
Nonalcoholic fatty liver disease
@en
type
label
Nonalcoholic fatty liver disease
@ast
Nonalcoholic fatty liver disease
@en
prefLabel
Nonalcoholic fatty liver disease
@ast
Nonalcoholic fatty liver disease
@en
P3181
P356
P1476
Nonalcoholic fatty liver disease
@en
P2093
P304
P3181
P356
10.1056/NEJMRA011775
P407
P577
2002-04-18T00:00:00Z